Form 4 Filing for Myriad Genetics Inc.

This filing details a transaction by Benjamin Richard Wheeler, Chief Financial Officer of Myriad Genetics Inc. On September 21, 2026, Mr. Wheeler disposed of 2,555 shares of common stock. The disposal was to cover tax withholding obligations related to the vesting of previously granted restricted stock units. The number of shares withheld was determined based on the closing stock price of $4.01 on the transaction date. Following this transaction, Mr. Wheeler owns 287,193 shares of common stock. The filing is a Form 4, indicating a change in beneficial ownership.